New Liquid Biopsy Technology Offers Hope in Diagnosing One of the Deadliest Cancers at an Early Stage...
South Korea’s Lunit signs major deal to deploy its AI diagnostic software across RAD-x, enhancing radiology workflows in over 20 German locations....
Final patient visit marks major milestone in FDA IDE study, advancing treatment options for patients not eligible for knee replacement....
New Fibrosis Biomarker Enhances Diagnostic Capabilities for Chronic Liver Disease Across Global Labs...
Innovative platform streamlines sample-to-result diagnostics, offering scalable, multiplexed solutions for global clinical laboratories....
Court Blocks Unauthorized Distribution of InMode’s RF Microneedling Devices and Cartridges in Major IP Protection Win ...
Company adopts ClearNote Health's early detection tool to identify pancreatic cancer at stage I, aiming to improve outcomes for high-risk individuals....
Marie® may soon become the first FDA-cleared upright particle therapy solution, aiming to reshape radiotherapy delivery across the U.S....
The partnership aims to deliver a non-invasive, hospital-compatible diagnostic using Aptamer’s Optimer binders and Neuro-Bio’s novel early-stage biomarker, with commercial rollout targeted within 12–18 months....
Marking its first investment in Asia and the cardiovascular gene therapy space, Angelini Ventures backs Singapore-based Nuevocor to drive clinical development of NVC-001 for LMNA DCM....
